DTC Marketing
Marcella Milliet Sciorra
The Future of Rare Disease Marketing is Patient-First and Privacy-SafeÂ
Swoop helps brands find, engage, and support rare disease patients earlier through privacy-safe, data-driven solutions.
Communities | Product Overviews
Swoop
Smarter Intelligence, Deeper Connection: Redefining Brand Marketing in 2026Â
Swoop's 2026 innovations build a truly patient-first marketing strategy.
Eric Peacock
Why AI is Fueling the Growth of Patient CommunitiesÂ
Google’s shift toward AI-generated answers removes blue search links often without clear attribution or context.
Swoop
Beyond the Buzz: A Practical Framework for AI-Powered Pharma MarketingÂ
Translate buzzwords into brand strategies that impact patient lives with this webinar featuring Romain Bogaerts.
Swoop
Beyond the Buzz: A Practical Framework for AI-Powered Pharma MarketingÂ
Translate buzzwords into brand strategies that impact patient lives with this webinar featuring Romain Bogaerts.
Swoop
83% of Chronic Condition Patients Surveyed Find Pharma Ads BeneficialÂ
Patient Perspectives on Pharmaceutical Advertising: Exclusive Insights from SwoopÂ
DTC Marketing | White Papers
Swoop
DSP Diagnosis: 10 Factors Pharma Marketers Should Consider
In today’s complex healthcare marketing landscape, selecting the right Demand-Side Platform (DSP) is crucial for pharmaceutical brands aiming to deliver impactful, targeted, and compliant omnichannel campaigns to patients and healthcare providers (HCPs). This checklist will guide you through the essential factors to consider, ensuring that your chosen DSP aligns with your marketing objectives, respects patient […]
DTC Audiences | Product Overviews
Swoop
Swoop DTC Audiences Overview
Reach 99% of your DTC target with Swoop’s 100% compliant audiences across all 50 states.
Eric Peacock
The Rare Disease Marketing Guide: 5 Strategies Every Pharma Marketer Needs To Know for Patient Engagement
R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases.
Eric Peacock
The New Marketing Playbook: Engaging Patients in the Era of AI, Personalization, Patient Privacy, and Direct-to-Patient Offerings
At MyHealthTeam’s all-company get-together in Nashville, we invited five pharma marketing experts from top agencies and biotechs to join me on a panel. We discussed the “New Marketing Playbook” for everything from rare disease launches to direct-to-patient models to innovative uses of AI with patients.